EMA To Up Transparency On Drug Safety By Publishing Risk Management Plans In Full

 
• By Vibha Sharma
  
White pills on leaflet about possible side effects and overdose
Companies are required to submit an RMP when applying for a marketing authorization • Source: Alamy

More from Drug Safety

More from Pink Sheet